Abstract
Background: Liver transplantation with neoadjuvant chemoradiation for localized, node negative hilar cholangiocarcinoma or cholangiocarcinoma in the setting of primary sclerosing cholangitis (PSC) in our institution achieves improved survival with fewer recurrences when compared to conventional resection. The emerging role and impact of EUS FNA in this setting of cholangiocarcinoma staging has yet to be determined. Aims: In eligible patients participating in this staging protocol to: 1) Determine the frequency of lymphadenopathy detected by EUS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
